Spring Bank Pharmaceuticals, Inc. announced the appointment of Atif Abbas, M.D., as Vice President, Head of Oncology & Immunology Clinical Development. Dr. Abbas is a pharmaceutical physician with nearly 20 years of clinical development, medical affairs and pharmacovigilance experience in oncology and immunology therapeutic areas. Prior to joining Spring Bank, he was associate vice president of clinical development in oncology at the biopharmaceutical company, Kadmon Inc. Prior to his work with Kadmon, he was a consultant physician at Ziopharm Oncology and Celgene Corp. where he provided scientific and medical expertise regarding drug development and clinical trials. Prior to this, he held roles of increasing responsibility in oncology clinical development and clinical safety at Merck KGaA, Astellas Pharma and Exelixis Inc. He has also held consultant physician roles with Bristol-Myers Squibb, Boehringer Ingelheim and Pfizer.